ArticleDrug delivery and translational research2022

Breast intraductal nanoformulations for treating ductal carcinoma in situ II: Dose de-escalation using a slow releasing/slow bioconverting prodrug strategy.

Firas Al-Zubaydi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.